Comments on "Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study

被引：4
|
作者：
Demb, HB [1 ]
Roychoudhury, K [1 ]
机构：
[1] Albert Einstein Coll Med, Rose F Kennedy Univ Affiliated Program, Childrens Evaluat & Dev Ctr, Bronx, NY 10461 USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2000年 / 20卷 / 05期
关键词：
D O I：
10.1097/00004714-200010000-00016
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：580 / 581
页数：2
相关论文
共 50 条
  • [11] Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: Results of an open-label study
    Buitelaar, JK
    van der Gaag, RJ
    van der Hoeven, J
    JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 (02) : 56 - 59
  • [12] A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders
    Posey, DJ
    Guenin, KD
    Kohn, AE
    Swiezy, NB
    McDougle, CJ
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2001, 11 (03) : 267 - 277
  • [13] Fluvoxamine is ineffective in the treatment of enuresis in children and adolescents: an open-label pilot study
    Toren, P
    Eldar, S
    Laor, N
    Wolmer, L
    Samuel, E
    Weizman, R
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2001, 16 (04) : 327 - 332
  • [14] Efficacy of Atomoxetine for the Treatment of ADHD Symptoms in Patients With Pervasive Developmental Disorders: A Prospective, Open-Label Study
    Fernandez-Jaen, Alberto
    Martin Fernandez-Mayoralas, Daniel
    Calleja-Perez, Beatriz
    Munoz-Jareno, Nuria
    Campos Diaz, Maria del Rosario
    Lopez-Arribas, Sonia
    JOURNAL OF ATTENTION DISORDERS, 2013, 17 (06) : 497 - 505
  • [15] An open-label study of olanzapine in children with PDD
    Kemner, C
    van Engeland, H
    Tuynman-Qua, H
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 194 - 194
  • [16] Open-label olanzapine treatment in five preadolescent children
    Krishnamoorthy, J
    King, BH
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 1998, 8 (02) : 107 - 113
  • [17] A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder
    Frazier, JA
    Biederman, J
    Tohen, M
    Feldman, PD
    Jacobs, TG
    Toma, V
    Rater, MA
    Tarazi, RA
    Kim, GS
    Garfield, SB
    Sohma, M
    Gonzalez-Heydrich, J
    Risser, RC
    Nowlin, ZM
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2001, 11 (03) : 239 - 250
  • [18] An open-label study of olanzapine in the first episode of schizophrenia in adolescents
    Dabokowska, M
    EUROPEAN PSYCHIATRY, 2002, 17 : 115S - 115S
  • [19] Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study
    Shella Schirman
    Sefi Kronenberg
    Alan Apter
    David Brent
    Nadine Melhem
    Nimrod Pick
    Miri Carmel
    Amos Frisch
    Abraham Weizman
    Doron Gothelf
    Journal of Neural Transmission, 2010, 117 : 139 - 145
  • [20] Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study
    Schirman, Shella
    Kronenberg, Sefi
    Apter, Alan
    Brent, David
    Melhem, Nadine
    Pick, Nimrod
    Carmel, Miri
    Frisch, Amos
    Weizman, Abraham
    Gothelf, Doron
    JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (01) : 139 - 145
12345